| ID | Sequence | Length | GC content |
|---|---|---|---|
| ACUUGCAAAUCGCUGUGUGCUCGCAGAAGCCAGCACUUCCACAGUCUCU… | 3301 nt | 0.4141 | |
| ACUUGCAAAUCGCUGUGUGCUCGCAGAAGCCAGCACUUCCACAGUCUCU… | 3432 nt | 0.4129 | |
| ACUUGCAAAUCGCUGUGUGCUCGCAGAAGCCAGCACUUCCACAGUCUCU… | 3077 nt | 0.4079 | |
| ACUUGCAAAUCGCUGUGUGCUCGCAGAAGCCAGCACUUCCACAGUCUCU… | 3438 nt | 0.4124 |
This gene encodes a type II classical cadherin of the cadherin superfamily. Alternative splicing of this gene results in multiple transcript variants. At least one of these variants encodes a preproprotein that is proteolytically processed to generate the mature cadherin protein. These integral membrane proteins mediate calcium-dependent cell-cell adhesion and are composed of a large N-terminal extracellular domain, a single membrane-spanning domain, and a small, highly conserved C-terminal cytoplasmic domain. The extracellular domain consists of 5 subdomains, each containing a cadherin motif, and appears to determine the specificity of the protein's homophilic cell adhesion activity. Type II (atypical) cadherins are defined based on their lack of a histidine-alanine-valine (HAV) cell adhesion recognition sequence specific to type I cadherins. This particular cadherin is predominantly expressed in brain and is putatively involved in synaptic adhesions, axon outgrowth and guidance. Mutations in this gene may be associated with lung squamous cell carcinoma and colorectal cancer in human patients. [provided by RefSeq, Nov 2015]
A study in human traumatic brain injury (TBI) patients identified CDH10 as a potential biomarker, showing it was part of multiple lncRNA-mRNA co-expression pairs within the differentially expressed network [Yang et al. DOI:10.4103/1673-5374.247467]. Specifically, the CDH10 was positively correlated with lncRNAs n340484 and n338875 and negatively correlated with lncRNA ENST00000441293 in the constructed network, indicating its involvement in the transcriptional response to TBI.